Financial Associated Press (Guangzhou, reporter Ren Chaoyu) news, due to the needs of anti-epidemic, related industries and listed companies in 2020 achieved explosive growth in performance. As an "anti-epidemic star stock", ST Shelley's ultraviolet disinfection business in 2020 recorded the best performance in the past five years, but in 2021, the income of related businesses fell year-on-year, and the company's secondary market was also in shock. How did the short-term stimulus of the pandemic evolve into a long-term driver? How does ST Shelley regain its growth in the "post-pandemic" era? These are the focus of investors' attention.
A few days ago, Chai Hua, general manager of ST Shelley, accepted an exclusive interview with a reporter from the Financial Associated Press, and for the first time shared the direction of cooperation between the company and Sinopharm Medical and the latest situation of ultraviolet disinfection business. Chai Hua pointed out that the normalization of epidemic prevention and control will provide a broader space for the ultraviolet killing business, and the company's performance increase will stem from the continuous extension and expansion of application scenarios. According to its disclosure, the company's ultraviolet killing technology in the field of cold chain logistics application products will soon be sold on the market, the future is also expected to expand to freight logistics, in order to seize the untapped blank market.
The "post-epidemic era" increment comes from the extension of application scenarios
During the anti-epidemic period, Shellette's ultraviolet disinfection business has seen explosive growth, and the revenue of ultraviolet lamp series products has reached 0.9 billion yuan, an increase of 60.55% over 2019, and it is also the highest performance in the past five years. However, in 2021, the revenue of ultraviolet lamp series products declined year-on-year.
General Manager Chai Hua said in an exclusive interview with the Financial Associated Press that during the epidemic in 2020, the company's ultraviolet disinfection products did have a serious shortage of supply online and offline, and then faced the urgent need of Vulcan Mountain and Leishenshan Hospital. Shellette was also recognized by the Ministry of Industry and Information Technology as a key guarantee enterprise for the prevention and control of the new crown pneumonia epidemic by the Ministry of Industry and Information Technology in early 2020.
But he also believes that the data for 2020 should not be used as a reasonable reference, it is "special, non-normalized", especially some of the company's small power, unconventional lamps sell more, it can be said that there are products that can be sold. In 2021, the company's conventional products have continued to grow. At the same time, some of the new terminal products developed by the company have finally landed in the isolation hotel supporting facilities, and actively promoted coverage in local schools.
Financial data show that from the first half of 2019 to the first half of 2021, the revenue of ST Shelley ultraviolet lamp series products was 0.34 billion yuan, 0.56 billion yuan and 0.37 billion yuan, respectively.
"In the future, the normalization of the epidemic situation, the mutation and increase of more and more various viruses and bacteria is a trend. Ultraviolet light as a broad-spectrum killing method is not limited to the elimination of the new crown virus, including influenza viruses every winter, avian influenza, etc. have a very good killing effect. In addition, in the past, the industry made a lamp, a single product. In recent years, the company has been helping relevant institutions to draft standards for the use of application sites such as schools. Put forward new ideas in product development, including products with human-machine coexistence. ”
"When the product is used, people will not be harmed, and now consumers can be safely served." Based on this, we hope that the application of ultraviolet rays has a good extension, not only medical, but also garbage disposal, cold chain disinfection, etc. The market for consumer-grade small household appliances will bring a very large market space. Chai Hua introduced.
On the other hand, in June 2020, Shellette signed the "Future Light" Strategic Cooperation Agreement with Guangzhou Huyan Institute Pharmaceutical Technology Co., Ltd., focusing on solving the problems of campus infection prevention and control, reducing cross-infection, and ensuring the health of teachers and students. The company revealed that related products can already be supplied in batches to meet the daily prevention and control needs of the campus. According to the company's official website, the landing project includes a number of primary and secondary schools in Guangzhou, Beijing and other places.
Chai Hua told reporters that the opportunity for cooperation between the company and Huyan Institute Of Medicine lies in the transformation of the campus infirmary. The infirmary was originally very simple, but under the need for epidemic prevention, special equipment was needed for the handling of emergency measures such as emergency isolation. Huyan Institute of Medicine is mainly responsible for the support of anti-epidemic prevention and special equipment, and Shellette is responsible for how ultraviolet lighting is applied to campus scenes.
Cleaning services and cold chain logistics will be important development directions
ST Shelley, which is under pressure to boost performance, recently reached a cooperation with Sinopharm Medical, injecting a dose of "peace of mind" into the secondary market. Chai Hua also publicly talked about the cooperation with Sinopharm for the first time in the interview, among which the application and expansion of the company's ultraviolet disinfection technology in cleaning services is the key direction of cooperation and exploration between the two sides.
Chai Hua revealed that the company and Sinopharm Medical will cooperate in several aspects in the future: First, product sales, Sinopharm Medical itself has a very strong sales channel, and has a certain leading position in the Chinese market. A series of products such as air disinfection and ultraviolet disinfection can jointly enter the Sinopharm medical hospital system; second, special product research and development can be carried out jointly with Sinopharm Medical, so that products can better serve this system; the third is cleaning services.
"Personally, I think this is a relatively new market, and the previous cleaning service was done by the logistics department of the hospital or unit. In the future, it will become an independent professional body to complete it, and now the overall trend has emerged. Because more also to take into account the discharge of some waste and the disposal of instruments, this requires a more professional and centralized approach to safety. Disinfection is also an important new demand, which is also a very important part of the cooperation between Shellette and Sinopharm. Apply our core killing technology to cleaning services to truly make it more standardized and effective. ”
Not only that, ST Shelley has also expanded its ultraviolet killing technology to the field of cold chain logistics, and existing products are about to be launched.
According to the reporter's understanding, since the outbreak of the epidemic, China's port cities have repeatedly caused local epidemics due to cold chain logistics virus residues, but the current cold chain logistics disinfection is still through the use of a large number of disinfectant water, there are certain drawbacks.
"First, disinfectant water can kill viruses but there are limitations, not that all viruses can kill. Second, the biggest drawback is the production of chemical secondary residues. If we use ultraviolet rays, there will be no drug residues, which will help protect the natural environment and human health and safety while achieving rapid elimination. In this regard, it has been certified by some landing projects and institutions. Chai Hua told reporters.
It is understood that the company will promote products similar to airport baggage disinfectors to freight, including express delivery companies, to seize the untapped blank market.
Similar to st shelley's encounter, many "anti-epidemic star stocks" are facing the problem of how to continue the performance growth momentum after spending the explosive growth in 2020. In terms of how to expand new space for anti-epidemic related products and businesses, ST Shelley's ideas are worth learning. However, it is worth noting that ST Shelley's cash flow is relatively tight. This has also led to companies being very cautious in the use of funds. At present, the company is alleviating the financial pressure by accelerating the recovery of accounts receivable, disposing of assets, promoting debt restructuring, and fixing increases, which is also an uncertain factor in whether the company can finally meet expectations.
This article originated from the Financial Associated Press
![Shelley Lyric Poetry Complete Edition: The Complete Edition of Shelley Lyric Poems in the West Wind Collection: Introduction to the Contents of the West Wind Collection · · ·[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)